BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23949591)

  • 21. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
    Kirkcaldy RD; Zaidi A; Hook EW; Holmes KK; Soge O; del Rio C; Hall G; Papp J; Bolan G; Weinstock HS
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):321-8. PubMed ID: 23460055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cephalosporin-Resistant Neisseria gonorrhoeae Isolated in Portugal, 2019.
    Pinto M; Matias R; Rodrigues JC; Duarte S; Vieira L; Gonçalves I; Gonçalves MJ; Ramos MH; Gomes JP; Borrego MJ
    Sex Transm Dis; 2020 Nov; 47(11):e54-e56. PubMed ID: 32530860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.
    Kirkcaldy RD; Kidd S; Weinstock HS; Papp JR; Bolan GA
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv5-10. PubMed ID: 24243881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters.
    Fekete T; Woodwell J; Cundy KR
    Antimicrob Agents Chemother; 1991 Mar; 35(3):497-9. PubMed ID: 1903910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of decreased susceptibility to extended-spectrum cephalosporins in Neisseria gonorrhoeae in India.
    Sood S; Mahajan N; Verma R; Kar HK; Sharma VK
    Natl Med J India; 2013; 26(1):26-8. PubMed ID: 24066990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
    Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
    J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimicrobial resistance in Neisseria gonorrheae in North-East Romania].
    Bădescu AC; Petrescu Z; Enache A; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):512-5. PubMed ID: 17983194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
    Lindberg R; Fredlund H; Nicholas R; Unemo M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2117-22. PubMed ID: 17420216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced susceptibility to cefixime but not ceftriaxone: an uncertain perspective for the treatment of gonorrhoea in Brazil.
    Costa-Lourenço APR; Abrams JA; Barros Dos Santos KT; Coelho-Souza T; Moreira BM; Fracalanzza SEL; Trees DL; Bonelli RR
    Int J Antimicrob Agents; 2017 Apr; 49(4):515-516. PubMed ID: 28232214
    [No Abstract]   [Full Text] [Related]  

  • 37. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
    Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M
    Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
    Bazzo ML; Golfetto L; Gaspar PC; Pires AF; Ramos MC; Franchini M; Ferreira WA; Unemo M; Benzaken AS;
    J Antimicrob Chemother; 2018 Jul; 73(7):1854-1861. PubMed ID: 29635367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.
    Carannante A; Prignano G; Cusini M; Matteelli A; Dal Conte I; Ghisetti V; D'Antuono A; Cavrini F; Antonetti R; Stefanelli P
    Clin Microbiol Infect; 2012 Jun; 18(6):558-64. PubMed ID: 21966997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.